No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US Stock MarketDetailed Quotes
ZNTL Zentalis Pharmaceuticals
- 3.000
- +0.070+2.39%
Close Dec 20 16:00 ET
- 3.000
- 0.0000.00%
Post 20:01 ET
213.80MMarket Cap-1.20P/E (TTM)
3.100High2.890Low1.85MVolume2.900Open2.930Pre Close5.57MTurnover3.59%Turnover RatioLossP/E (Static)71.27MShares18.07052wk High0.60P/B154.86MFloat Cap2.66052wk Low--Dividend TTM51.62MShs Float87.190Historical High--Div YieldTTM7.17%Amplitude2.660Historical Low3.006Avg Price1Lot Size
Full Hours
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Lexeo Therapeutics Appoints Kyle Rasbach as CFO
Zentalis Pharmaceuticals Appoints Wendy Chang as Chief People Officer >ZNTL
Zentalis Pharmaceuticals Announces Key Management Appointments
Express News | Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Press Release: Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Guggenheim Maintains Zentalis Pharmaceuticals(ZNTL.US) With Buy Rating, Cuts Target Price to $8
Heat List
US
Overall
Symbol
Price
% Chg
No Data